logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Theratechnologies Inc.

TH.TO

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibā€¦ read more

Healthcare

Drug Manufacturersā€”Specialty & Generic

27 years

CAD

Exclusive to Premium users

Price

per share adjusted in CAD

$4.48

Price

+0.22%

$0.01

$4.47

Previous Close

$4.42

Open

Premium

52w Discount
Market Cap

$205.990m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$84.378m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$9.157m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$0.19

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

-$27.922m

$51.269m

Assets

$79.191m

Liabilities

$43.621m

Debt
Debt to Assets

85.1%

21.3x

Debt to EBITDA
Free Cash Flow

-$3.076m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
ā†‘ TopSummaryPriceFinancials
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.